Tumor-Liver FGF21 and IGFBP1 Pathway Drives Musculoskeletal Wasting in Colorectal Cancer
Researchers identified a tumor-liver endocrine relay involving FGF21 and IGFBP1 that drives muscle and bone wasting in colorectal cancer models.
Researchers identified a tumor-liver endocrine relay involving FGF21 and IGFBP1 that drives muscle and bone wasting in colorectal cancer models.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.